PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis

Int J Mol Sci. 2020 Apr 21;21(8):2902. doi: 10.3390/ijms21082902.

Abstract

Phosphodiesterase 2A (PDE2A) is a cAMP-cGMP hydrolyzing enzyme essential for mouse development and the PDE2A knockout model (PDE2A-/-) is embryonic lethal. Notably, livers of PDE2A-/- embryos at embryonic day 14.5 (E14.5) have extremely reduced size. Morphological, cellular and molecular analyses revealed loss of integrity in the PDE2A-/- liver niche that compromises the hematopoietic function and maturation. Hematopoietic cells isolated from PDE2A-/- livers are instead able to differentiate in in vitro assays, suggesting the absence of blood cell-autonomous defects. Apoptosis was revealed in hepatoblasts and at the endothelial and stromal compartments in livers of PDE2A-/- embryos. The increase of the intracellular cAMP level and of the inducible cAMP early repressor (ICER) in liver of PDE2A-/- embryos might explain the impairment of liver development by downregulating the expression of the anti-apoptotic gene Bcl2. In summary, we propose PDE2A as an essential gene for integrity maintenance of liver niche and the accomplishment of hematopoiesis.

Keywords: ICER; apoptosis; cAMP; fetal liver; hematopoiesis; phosphodiesterase 2A.

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Biomarkers
  • Cell Differentiation
  • Cyclic Nucleotide Phosphodiesterases, Type 2 / genetics*
  • Cyclic Nucleotide Phosphodiesterases, Type 2 / metabolism
  • Endothelial Cells / metabolism
  • Endothelium / metabolism
  • Genotype
  • Hematopoiesis / genetics*
  • Immunohistochemistry
  • Liver / embryology*
  • Liver / metabolism*
  • Mice
  • Mice, Transgenic
  • Mutation
  • Organogenesis / genetics*
  • Stem Cells / cytology
  • Stem Cells / metabolism
  • Stromal Cells / metabolism

Substances

  • Biomarkers
  • Cyclic Nucleotide Phosphodiesterases, Type 2
  • Pde2a protein, mouse